An individual enters a Walgreens retailer in San Francisco, California, U.S., on Tuesday, April 13, 2021.
David Paul Morris | Bloomberg | Getty Photographs
Walgreens Boots Alliance on Thursday topped analysts’ expectations for fiscal second-quarter earnings, after the omicron variant intensified demand for Covid booster pictures and assessments throughout the winter months.
The pharmacy chain reiterated its outlook for the yr. It has mentioned that adjusted earnings per share will develop within the low single digits.
Shares rose about 2% in premarket buying and selling.
This is what Walgreens reported in contrast with what analysts had been anticipating for the second quarter ended Feb. 28, primarily based on Refinitiv information:
- Earnings per share: $1.59 adjusted vs. $1.40 anticipated
- Income: $33.76 billion vs. $33.4 billion anticipated
Within the quarter, web revenue fell to $883 million, or $1.02 per share, from $1.03 billion, or $1.19 per share, within the year-ago interval.
Excluding objects, the corporate earned $1.59 per share, exceeding the $1.40 anticipated by analysts surveyed by Refinitiv.
Gross sales fell to $33.76 billion from $32.78 billion a yr earlier, however surpassed the $33.4 billion that analysts anticipated.
As of Wednesday’s shut, Walgreens shares are down 9% up to now this yr. Shares closed Wednesday at $47.46, bringing the corporate’s market worth to $40.97 billion.
This story is creating. Please verify again for updates.